Your browser doesn't support javascript.
loading
Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations.
Yanwei, Zhang; Bo, Jin; Yuqing, Lou; Rong, Li; Xueyan, Zhang; Song, Hu; Baohui, Han.
Affiliation
  • Baohui H; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic China.
J Cancer Res Ther ; 12(1): 254-8, 2016.
Article in En | MEDLINE | ID: mdl-27072247
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoembryonic Antigen / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Cancer Res Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2016 Document type: Article Country of publication: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoembryonic Antigen / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Cancer Res Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2016 Document type: Article Country of publication: India